Badmann, Susann
Mayr, Doris
Schmoeckel, Elisa
Hester, Anna
Buschmann, Christina
Beyer, Susanne
Kolben, Thomas
Kraus, Fabian
Chelariu-Raicu, Anca
Burges, Alexander
Mahner, Sven
Jeschke, Udo
Trillsch, Fabian
Czogalla, Bastian
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 14 June 2021
Accepted: 18 January 2022
First Online: 3 February 2022
Competing interests
: T.K. holds stock of Roche AG and his relative is employed at Roche AG. A.H. has received a research grant from the “Walter Schulz” foundation and advisory board, speech honoraria and travel expenses from Roche and Pfizer. A.B. has received advisory board and honoraria from AstraZeneca, Clovis, Roche and Tesaro. Research support, advisory board, honoraria, and travel expenses from AstraZeneca, Clovis, Medac, MSD, Novartis, PharmaMar, Roche, Sensor Kinesis, Tesaro, Teva have been received by S.M. and from AstraZeneca, Medac, PharmaMar, Roche, Tesaro by F.T. The other authors declare no competing interests.